Germany Berlin Chemical Co., Ltd. Beijing Office

To evaluate the efficacy and safety of dexketoprofen tromethamine injection for postoperative analgesia, with placebo as control, and to reduce the cumulative morphine consumption within 24 hours

To investigate the time-dependent changes in blood drug concentration after single and multiple intravenous infusions of dexketoprofen trometamol injection in healthy volunteers and the time-dependent excretion of urinary drugs after a single intravenous infusion, to evaluate its pharmacokinetic characteristics in humans, and to provide a reference for clinical research

To evaluate the safety and efficacy of dexketoprofen tromethamine injection in the treatment of postoperative pain